Dr. Vinay Prasad succeeds Dr. Peter Marks, who left the role of leader of the FDA’s Center for Biologics Evaluation and ...

The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics ...

Five years after the onset of the COVID-19 pandemic, 42 percent of people in the U.S. think federal health agencies are ...

A blanket requirement for placebo-controlled trials threatens research ethics and vaccine access, it’s being argued.

Robert F. Kennedy Jr., who oversees the FDA, intends to set new regulatory standards vaccine manufacturers couldn’t possibly ...